The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โABBVโ.
AbbVie (stock symbol: ABBV) dividend yield (TTM) as of April 26, 2024 : 2.70%
Average dividend yield, last 5 years: 4.16%
Date | Dividend Yield |
---|---|
2024-04-12 | 2.78% |
2023-12-29 | 3.82% |
2022-12-30 | 3.49% |
2021-12-31 | 3.84% |
2020-12-31 | 4.41% |
2019-12-31 | 4.83% |
2018-12-31 | 3.89% |
2017-12-29 | 2.65% |
2016-12-30 | 3.64% |
2015-12-31 | 3.41% |
2014-12-31 | 2.54% |
2013-12-31 | 3.03% |
Name | Dividend yield | Country |
---|---|---|
Pfizer PFE | 6.53% | ๐บ๐ธ USA |
Eli Lilly LLY | 0.65% | ๐บ๐ธ USA |
Amgen AMGN | 3.21% | ๐บ๐ธ USA |
Biogen BIIB | 0.00% | ๐บ๐ธ USA |
Gilead Sciences GILD | 3.45% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | 3.89% | ๐บ๐ธ USA |
AstraZeneca AZN | 1.93% | ๐ฌ๐ง UK |
GlaxoSmithKline GSK | 3.56% | ๐ฌ๐ง UK |
Neurocrine Biosciences
NBIX | 0.00% | ๐บ๐ธ USA |